Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
Jean‐Philippe Julien(University of Toronto), Andrew B. Ward(Scripps Research Institute), Jeong Hyun Lee(Scripps Research Institute), C. Richter King(GenVec), Albert Cupo(Cornell University), Per Johan Klasse(Cornell University), Ronald Derking(Amsterdam UMC Location University of Amsterdam), Charles D. Murin(Scripps Research Institute), Michael J. Caulfield(United States Military Academy), Rogier W. Sanders(Scripps Research Institute), Simon Hoffenberg(International AIDS Vaccine Initiative), Ian A. Wilson(Raigmore Hospital), Andre J. Marozsan(Cornell University), John P. Moore(Cornell University)
Cited by 247
Related Papers
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|PLoS Pathogens|2013|1k
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
|Nature Communications|2019|948
Highly Conserved Protective Epitopes on Influenza B Viruses
|Science|2012|916